Effectiveness of the 2023-2024 monovalent XBB.1.5 vaccine against SARS-CoV-2 infection in people aged over 65 years in South Korea: a population-based cohort study

Objectives: The continued emergence of SARS-CoV-2 variants, including XBB.1.5 and its sublineages, poses challenges for COVID-19 control, particularly in high-risk populations. This study evaluated the community-based effectiveness of the 2023-2024 monovalent XBB.1.5 vaccine in preventing SARS-CoV-2...

全面介绍

书目详细资料

Principais autores:	Suyoung Jo, Seunghyun Lee, Huiseon Kim, Hyunji Won, Gi-eun Rhie, Hye-Sook Jeong, June-Woo Lee, Ah-Ra Kim, Byung Chul Chun, Kyong Ran Peck, Dong-Hyun Kim
格式:	Artigo
语言:	Inglês
出版:	Elsevier 2026-02-01
丛编:	International Journal of Infectious Diseases
主题:	COVID-19 Vaccine effectiveness K-SEROSMART Population-based cohort study Nested case-control study
在线阅读:	http://www.sciencedirect.com/science/article/pii/S1201971225004606
标签:	添加标签 没有标签, 成为第一个标记此记录!